Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8HZW

The NMR structure of noursinH11W peptide

Summary for 8HZW
Entry DOI10.2210/pdb8hzw/pdb
DescriptornoursinH11W (1 entity in total)
Functional Keywordscyclic peptide, histidine-to-butyrine crosslink, histidinobutyrine, unknown function
Biological sourceStreptomyces noursei ATCC 11455
Total number of polymer chains1
Total formula weight1669.97
Authors
Yao, H.,Li, Y.,Zhang, T.,Gao, J.,Wang, H. (deposition date: 2023-01-09, release date: 2023-05-31, Last modification date: 2024-05-08)
Primary citationLi, Y.,Ma, Y.,Xia, Y.,Zhang, T.,Sun, S.,Gao, J.,Yao, H.,Wang, H.
Discovery and biosynthesis of tricyclic copper-binding ribosomal peptides containing histidine-to-butyrine crosslinks.
Nat Commun, 14:2944-2944, 2023
Cited by
PubMed Abstract: Cyclic peptide natural products represent an important class of bioactive compounds and clinical drugs. Enzymatic side-chain macrocyclization of ribosomal peptides is a major strategy developed by nature to generate these chemotypes, as exemplified by the superfamily of ribosomally synthesized and post-translational modified peptides. Despite the diverse types of side-chain crosslinks in this superfamily, the participation of histidine residues is rare. Herein, we report the discovery and biosynthesis of bacteria-derived tricyclic lanthipeptide noursin, which is constrained by a tri amino acid labionin crosslink and an unprecedented histidine-to-butyrine crosslink, named histidinobutyrine. Noursin displays copper-binding ability that requires the histidinobutyrine crosslink and represents the first copper-binding lanthipeptide. A subgroup of lanthipeptide synthetases, named LanKC, were identified to catalyze the formation of both the labionin and the histidinobutyrine crosslinks in precursor peptides and produce noursin-like compounds. The discovery of the histidinobutyrine-containing lanthipeptides expands the scope of post-translational modifications, structural diversity and bioactivity of ribosomally synthesized and post-translational modified peptides.
PubMed: 37221219
DOI: 10.1038/s41467-023-38517-2
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon